EFFECT ·Filed Aug 7, 2026

IMA

ImageneBio, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed1mo ago SEC9999999995-26-002555
IPO/offering going effective
Actionable Insight ▼ Bearish

Monitor for a prospectus supplement or takedown notice that would specify the size, price, and terms of any offering. The shelf enables the company to raise capital at its discretion, which may pressure the stock if a significant dilutive offering materializes.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
IMA ▼ -14.76% at T+20d
SHORT call ✓ call won +14.76% · α vs SPY +14.37% · entry $5.69 → $4.85
Next anchor: T+60d in 4w
Latest observation: T+38 +12.43% FF3 residual α
Entry anchored
Aug 6, 04:00 PM ET
via 1-min bar
T+1d
+0.53%
call -0.53% · α -0.56%
$5.72
settled 8w ago
T+5d
+2.64%
call -2.64% · α -2.24%
$5.84
settled 7w ago
T+20d
-14.76%
call +14.76% · α +14.37%
$4.85
settled 28d ago
T+60d
—
call — · α —
—
in 4w

Price Chart

Loading chart...

Executive Summary

ImageneBio's registration statement (File No. 333-290108) became effective on August 6, 2026, under the Securities Act of 1933. This enables the company to sell securities pursuant to the shelf registration, creating a potential dilution overhang for existing shareholders.

Key Facts

  • Effectiveness date: 2026-08-06
  • SEC File No.: 333-290108
  • Act: Securities Act of 1933 (33 Act)
  • Shelf registration became effective; no specific terms of offering disclosed

Financial Impact

No offering amount, price, or number of shares specified in the effectiveness notice; dilution potential exists but is unquantifiable from this filing alone

dilution

Risk Factors

  • Potential dilution to existing shareholders upon any future shelf takedown
  • No disclosure of intended use of proceeds or timing of offering

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
71% bullish (7 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002555
Document: 9999999995-26-002555-index.html9999999995-26-002555
Document: 9999999995-26-002555.txt9999999995-26-002555
8 reports for IMA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMA — sortable, filterable
TypeNow
Aug 7, 2026
8w ago
EFFECT
BEARISH ★ 5/10
$5.69 $4.85▲ +14.76%▲ +14.37%$4.60 (+19.16%)
Jun 26, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$6.07 $5.59▼ −7.91%▼ −7.63%$4.60 (−24.22%)
Apr 30, 2026
22w ago
DEFA14A
NEUTRAL ★ 3/10
$5.66 $5.47▼ −3.36%▼ −8.62%$4.60 (−18.73%)
Apr 13, 2026
24w ago
8-K
BEARISH ★ 6/10
$6.05 $5.61▲ +7.27%▲ +15.00%$4.60 (+23.97%)
Apr 13, 2026
24w ago
Press Release
BEARISH ★ 6/10
$6.05 $5.61▲ +7.27%▲ +15.00%$4.60 (+23.97%)
Apr 6, 2026
25w ago
EFFECT
NEUTRAL ★ 3/10
$4.55 $5.72▲ +25.60%▲ +16.62%$4.60 (+1.10%)
Mar 17, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$5.83 $5.78▼ −0.77%▼ −6.82%$4.60 (−21.03%)
Mar 10, 2026
29w ago
Press Release
NEUTRAL ★ 4/10
$6.07 $4.57▼ −24.71%▼ −24.56%$4.60 (−24.22%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (64h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access